Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Number of holders
-
167
-
Total 13F shares, excl. options
-
21,616,772
-
Shares change
-
+279,522
-
Total reported value, excl. options
-
$1,145,533,854
-
Value change
-
+$16,564,346
-
Put/Call ratio
-
78%
-
Number of buys
-
72
-
Number of sells
-
-74
-
Price
-
$53.01
Significant Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q2 2020
184 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q2 2020.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 167 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21,616,772 shares
of 834,731,296 outstanding shares and own 2.6% of the company stock.
Largest 10 shareholders include ROYAL BANK OF CANADA (3,655,721 shares), RENAISSANCE TECHNOLOGIES LLC (2,351,938 shares), GOLDMAN SACHS GROUP INC (1,428,120 shares), VANGUARD GROUP INC (1,045,044 shares), BlackRock Inc. (1,030,722 shares), STATE STREET CORP (1,023,261 shares), DIMENSIONAL FUND ADVISORS LP (813,001 shares), Aperio Group, LLC (758,254 shares), SCHRODER INVESTMENT MANAGEMENT GROUP (562,034 shares), and Parametric Portfolio Associates LLC (521,000 shares).
This table shows the top 167 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.